Response to “In vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement”

類似資料

• In vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement
  著者:: Compte, Marta, 等
  出版事項: (2015)
• Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo
  著者:: Zhong, Liping, 等
  出版事項: (2021)
• Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma.
  著者:: Thanich Sangsuwannukul, 等
  出版事項: (2022-01-01)
• Costimulatory T cell engagement via a novel bispecific anti-CD137 /anti-HER2 protein
  著者:: Hinner, Marlon J, 等
  出版事項: (2015)
• T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies
  著者:: Velasquez, Mireya Paulina, 等
  出版事項: (2016)